Bacteremia, Antibodies Link Periodontal Disease and RA Bacteremia, Antibodies Link Periodontal Disease and RA
Periodontal disease may introduce bacteria into the bloodstream that trigger immune responses in patients with rheumatoid arthritis, new research suggests.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 27, 2023 Category: Consumer Health News Tags: Rheumatology News Source Type: news

I Feel Like I ’m Burning Alive. It ’ s Hard for People to Believe Me
In 2018, I woke up on my birthday around 2 or 3 a.m. with a funny feeling in my left hand. It started as a slight itch on my thumb that quickly morphed into a different sensation—the feeling of the thumb beginning to swell, followed by the same feeling in my fingers and sections of my palm, until my hand was almost double its normal size. Later that morning, I visited an orthopedist I’d seen once or twice before for other reasons. He gave me a shot to prevent further swelling, and I went on my way. It was an unremarkable visit. Soon after, another strange thing happened: My hands began to feel like they were on...
Source: TIME: Health - February 24, 2023 Category: Consumer Health News Authors: Je Banach Tags: Uncategorized Evergreen freelance health Source Type: news

Lupus, RA Tied to Higher Risk for Adverse Obstetric, Birth Outcomes
THURSDAY, Feb. 23, 2023 -- Women with rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) and their infants experience higher rates of adverse obstetric and birth outcomes, according to a study published online Jan. 10 in Arthritis Care... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 23, 2023 Category: Pharmaceuticals Source Type: news

Alcohol Consumption Tied to Less Disease Activity With Rheumatoid Arthritis
WEDNESDAY, Feb. 22, 2023 -- There is an inverse relationship between alcohol consumption and disease activity in people with rheumatoid arthritis, according to a study published online Jan. 11 in Arthritis& Rheumatology. Lars Alfredsson,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 23, 2023 Category: Pharmaceuticals Source Type: news

Study Suggests Path Connecting Periodontal Disease With Rheumatoid Arthritis
(MedPage Today) -- The anti-citrullinated protein antibodies (ACPAs) seen in many rheumatoid arthritis (RA) patients -- which serve as a diagnostic marker and could also play an etiologic role -- may have their origin in periodontal disease... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - February 22, 2023 Category: Primary Care Source Type: news

Evidence Found of Causal Link for Multisite Chronic Pain and MS, RA
WEDNESDAY, Feb. 22, 2023 -- Multisite chronic pain is causally associated with a higher risk for multiple sclerosis (MS) and rheumatoid arthritis (RA), but not with other autoimmune diseases (AIDs), according to a study published online Feb. 9 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 22, 2023 Category: Pharmaceuticals Source Type: news

Women ’s equality at risk of being put back 25 years by the pandemic
More than 50 years after the Equal Pay Act was passed, women at work and in retirement continue to face widespread discrimination – and the situation has worsened since the pandemic, UNISON’s annual women’s conference heard last week. According to the Office of National Statistics, the gender pay gap currently stands at 15% for full-time workers and is much wider when employed part-time, as most women are. Working years Proposing a motion ‘gender pay justice for women workers’, Kate Ramsden of Scotland region (pictured above) told delegates: “Workers – mainly women – stepped up during COVID to keep this cou...
Source: UNISON Health care news - February 20, 2023 Category: UK Health Authors: Demetrios Matheou Tags: Article News 2023 National Womens Conference equal pay equality Source Type: news

UCLA receives $20 million to establish Goodman –Luskin Microbiome Center
Key takeawaysA $20 million gift from Andrea and Donald Goodman and Renee and Meyer Luskin will fund a new center at UCLA focused on the microbiome and its effect on health.Investigators  at the new center will study the microbiome’s role in disease prevention and the body’s immune response.The enterprise will be led by Elaine Hsiao,  UCLA ’s De Logi Professor of Biological Sciences.Among the most promising areas of scientific inquiry is the study of the human microbiome and its effect on health. To fuel more rapid progress in this field, Andrea and Donald Goodman and Renee and Meyer Luskin have made a $20 million g...
Source: UCLA Newsroom: Health Sciences - February 15, 2023 Category: Universities & Medical Training Source Type: news

Effect of Targeted RA Therapies on Inflammation and Anemia Effect of Targeted RA Therapies on Inflammation and Anemia
In what ways do various targeted DMARDs impact systemic inflammation and anemia in patients with rheumatoid arthritis?Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 14, 2023 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Drug used by arthritis patients may be key to 'longer lifespan' - turns ageing blood young
The medication, used by people with rheumatoid arthritis, was shown to block the deterioration of blood stem cells in a new study. (Source: Daily Express - Health)
Source: Daily Express - Health - February 9, 2023 Category: Consumer Health News Source Type: news

Janssen Reports Positive Topline Phase 2 Results for Nipocalimab in Pregnant Individuals at High Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
SPRING HOUSE, PENNSYLVANIA, February 6, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced positive topline results from the proof-of-concept Phase 2 open-label UNITY clinical trial for the treatment of pregnant adults at high risk for severe hemolytic disease of the fetus and newborn (HDFN). HDFN is a serious and rare condition which can cause life-threatening anemia in the fetus. It occurs when the blood types of a pregnant individual and their fetus are incompatible.1 The trial met the primary endpoint, with the majority of pregnant patients who received nipocalimab achieving a live b...
Source: Johnson and Johnson - February 8, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news

Correction to: Clinical and biomechanical factors associated with falls and rheumatoid arthritis: baseline cohort with longitudinal nested case-control study - The editors.
This is a correction to: Rheumatology, Volume 61, Issue 2, February 2022, Pages 679-687, https://doi.org/10.1093/rheumatology/keab388 This is a correction to: Toby O Smith, Celia Clarke, Jacob Wells, Jack R Dainty, Laura Watts, Max Yates, Valerie M Pome... (Source: SafetyLit)
Source: SafetyLit - February 6, 2023 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Environmental influences on rheumatoid arthritis explored in lecture
<img width="100" src="https://factor.niehs.nih.gov/sites/niehs-factor/files/styles/thumbnail/public/2023/01/feature/holers-v-michael-thumb.jpg?itok=qJP-Yzlm" /><br /><p>NIEHS Distinguished Lecturer discussed the promise of modifying environmental and other risk factors during earliest disease stage.</p> (read more) (Source: Environmental Factor - NIEHS Newsletter)
Source: Environmental Factor - NIEHS Newsletter - February 3, 2023 Category: Environmental Health Source Type: news

Rheumatoid Factor and ACPA, Meet Potential New Partners for RA Diagnosis
(MedPage Today) -- Antibodies to peptides not currently used for rheumatoid arthritis (RA) diagnosis helped identify patients with untreated early disease that conventional biomarkers missed, researchers said. Almost two-thirds of blood samples... (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - February 3, 2023 Category: Rheumatology Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Roche reports good results for 2022 despite decline in demand for COVID-19 products
Basel, 2 February 2023Group sales grow by 2%1 at constant exchange rates (CER) and 1% in Swiss francs, despite lower COVID-19-related sales in both divisionsPharmaceuticals Division salesincrease by 2%; continued strong growth of newer medicines more than compensating for the impact of biosimilars and lower sales of Actemra/RoActemra (severe COVID-19)Diagnostics Division salesgrow by 3%; ongoing strong momentum in base business (+7%) more than compensating for the continuing decline in the demand for COVID-19 tests in the second half of the yearHighlightsin the fourth quarter of 2022 (incl. January 2023):US approvals ofLun...
Source: Roche Media News - February 2, 2023 Category: Pharmaceuticals Source Type: news